✦ LIBER ✦

CA 125 and CA 19-9 immunolocalization in normal, hyperplastic, and carcinomatous endometrium

✍ Scribed by Edward Podczaski; Paul F. Kaminski; Richard Zaino

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 639 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930415)71:8<2551::aid-cncr2820710819>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carcinoembryonic antigen, CA 19-9, and C

Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue

✍ Armin Quentmeier; Peter Möller; Volker Schwarz; Ulrich Abel; Peter Schlag 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

Normal bronchial mucus contains high lev

Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen

✍ Yoichiro Matsuoka; Keigo Endo; Yasutaka Kawamura; Toshimichi Yoshida; Tsuneo Sag 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

Evaluation of five glycoprotein tumour m

Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma

✍ Kjell Grankvist; Börje Ljungberg; Torgny Rasmuson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

Increased levels of glycoprotein tumour markers have been observed in sera of patients with renal-cell carcinoma. Five different glycoprotein markers [carcinoembryonic antigen (CEA), CA-50, CA-19-9, CA-125 and CA-15-3] were assessed in 154 consecutive patients with renal-cell carcinoma before initia

CA 19-9 and CA 50 in Benign and malignan

CA 19-9 and CA 50 in Benign and malignant pancreatic and biliary diseases

✍ Michela Paganuzzi; Marina Onetto; Paola Marroni; Daniela Barone; Massimo Conio; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

Serum concentrations of the CA 19-9 and CA 50 antigens were determined in 129 patients with malignant and benign biliary and pancreatic diseases. Values for the two markers were highly correlated (P < 0.001). The concentrations of CA 19-9 and CA 50 were positive in 84.6% and 80.7% of patients with p

Elevation of CA 19-9 and chromogranin A,

Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis

✍ Kuo-Chien Tsao; Ji-Hong Hong; Tsu-Lan Wu; Pi-Yueh Chang; Chien-Feng Sun; James T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract As the best‐known tumor marker for ovarian carcinoma, CA 125 has also been commonly used to monitor patients with common benign gynecologic diseases such as endometriosis and leiomyoma. Both of these benign tumors are known to be at risk of developing into cancer. During the screening o

CEA, CA 19-9, and CA 125 in the differen

CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice

✍ Nüvit Duraker; Semih Hot; Yücel Polat; Anil Höbek; Nur Gençler; Nuray Urhan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract ## Background and Objectives In this study, the value of the serum tumor markers carcinoembryonic antigen (CEA), CA 19‐9, and CA 125 was assessed in the differential diagnosis of benign and malignant pancreatic diseases with and without obstructive jaundice. ## Methods Serum levels o